Rebecca L Robinson

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi request reprint Economic cost and epidemiological characteristics of patients with fibromyalgia claims
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 30:1318-25. 2003
  2. ncbi request reprint In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review
    Rebecca L Robinson
    Eli Lilly and Company, US Medical Division, Outcomes Research, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Expert Opin Pharmacother 7:1027-39. 2006
  3. doi request reprint Burden of illness and treatment patterns for patients with fibromyalgia
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Pain Med 13:1366-76. 2012
  4. ncbi request reprint Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims
    Rebecca L Robinson
    Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Manag Care Pharm 12:43-54. 2006
  5. ncbi request reprint Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 31:1621-9. 2004
  6. doi request reprint Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana
    Pain Med 14:1400-15. 2013
  7. ncbi request reprint Impact of pain on depression treatment response in primary care
    Matthew J Bair
    Regenstrief Institute and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Psychosom Med 66:17-22. 2004
  8. ncbi request reprint Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance
    Robert L Obenchain
    US Medical Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana, USA
    J Biopharm Stat 15:419-36. 2005
  9. pmc Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
    Wenyu Ye
    Lilly USA, LLC, Indianapolis, Indiana, USA
    BMC Psychiatry 11:19. 2011
  10. ncbi request reprint Depression and pain comorbidity: a literature review
    Matthew J Bair
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Arch Intern Med 163:2433-45. 2003

Detail Information

Publications18

  1. ncbi request reprint Economic cost and epidemiological characteristics of patients with fibromyalgia claims
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 30:1318-25. 2003
    ..We investigated the total costs of FM in an employer population...
  2. ncbi request reprint In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review
    Rebecca L Robinson
    Eli Lilly and Company, US Medical Division, Outcomes Research, Lilly Corporate Center, Indianapolis, IN 46285, USA
    Expert Opin Pharmacother 7:1027-39. 2006
    ..Medical professionals should be a driving force in understanding the clinical and economic challenges of fibromyalgia...
  3. doi request reprint Burden of illness and treatment patterns for patients with fibromyalgia
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Pain Med 13:1366-76. 2012
    ....
  4. ncbi request reprint Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims
    Rebecca L Robinson
    Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Manag Care Pharm 12:43-54. 2006
    ....
  5. ncbi request reprint Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Rheumatol 31:1621-9. 2004
    ..Both syndromes share common symptoms and impose significant economic burdens. This study compared claims for treatment and costs of FM plus depression with those for FM or depression alone...
  6. doi request reprint Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study
    Rebecca L Robinson
    Eli Lilly and Company, Indianapolis, Indiana
    Pain Med 14:1400-15. 2013
    ..To describe 12-month treatment patterns and outcomes for patients starting a new medication for fibromyalgia in routine clinical practice...
  7. ncbi request reprint Impact of pain on depression treatment response in primary care
    Matthew J Bair
    Regenstrief Institute and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Psychosom Med 66:17-22. 2004
    ..Pain commonly coexists with depression, but its impact on treatment outcomes has not been well studied. Therefore, we prospectively evaluated the impact of comorbid pain on depression treatment response and health-related quality of life...
  8. ncbi request reprint Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance
    Robert L Obenchain
    US Medical Outcomes Research, Eli Lilly and Company, Indianapolis, Indiana, USA
    J Biopharm Stat 15:419-36. 2005
    ..In contrast, extensive follow-up comparisons using data from actual clinical practice will almost always ultimately be needed to better inform health policy makers...
  9. pmc Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
    Wenyu Ye
    Lilly USA, LLC, Indianapolis, Indiana, USA
    BMC Psychiatry 11:19. 2011
    ....
  10. ncbi request reprint Depression and pain comorbidity: a literature review
    Matthew J Bair
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Arch Intern Med 163:2433-45. 2003
    ..A model that incorporates assessment and treatment of depression and pain simultaneously is necessary for improved outcomes...
  11. ncbi request reprint Appropriateness of prescribing practices for serotonergic antidepressants
    Danielle L Loosbrock
    Eli Lilly Company, Indianapolis, IN 46285, USA
    Psychiatr Serv 53:179-84. 2002
    ..Data from prescribing physicians were used to assess whether serotonergic antidepressants were used for appropriate indications and at appropriate initial dosages...
  12. pmc Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study
    Madelaine M Wohlreich
    Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Indiana, USA
    Prim Care Companion J Clin Psychiatry 9:271-9. 2007
    ..Clinical Trials Registration: ClinicalTrials.gov identifier NCT00479726...
  13. ncbi request reprint The economic burden of depression with painful symptoms
    Paul E Greenberg
    Analysis Group Economics, Inc, Boston, MA 02199, USA
    J Clin Psychiatry 64:17-23. 2003
    ..However, more research is needed to assess the comprehensive economic impact that depression with painful physical symptoms can have on society...
  14. doi request reprint Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss
    Leigh Ann White
    Analysis Group, Inc, 111 Huntington Avenue, Boston, MA 02199, USA
    J Occup Environ Med 50:13-24. 2008
    ..To compare 2005 health care resources among matched samples of employees with fibromyalgia (FM), osteoarthritis (OA), and controls...
  15. ncbi request reprint Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs
    Nicholas P Emptage
    Department of Health Management and Policy, University of Michigan, 109 Observatory Street, Ann Arbor, Michigan 48109, USA
    Psychiatr Serv 56:468-74. 2005
    ..Individuals with depression commonly experience pain with unclear pathology. This study examined depression and comorbid pain and associated outcomes over six years in a nationally representative cohort of older Americans...
  16. ncbi request reprint Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain
    Eric Q Wu
    Analysis Group, Inc, Boston, Massachusetts 02199, USA
    J Pain 7:399-407. 2006
    ..06). These results, however, reflect the controlled environment of a clinical trial. An analysis of real-world data would be beneficial...
  17. ncbi request reprint Labor market, financial, insurance and disability outcomes among near elderly Americans with depression and pain
    Haijun Tian
    Pardee RAND Graduate School, Santa Monica, CA 90407 2138, USA
    J Ment Health Policy Econ 8:219-28. 2005
    ..Does this comorbidity account for a large share of the adverse social outcomes attributed to depression?..
  18. ncbi request reprint Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review
    Amy M Barrett
    RTI Health Solutions, Research Triangle Park, North Carolina 27709 2194, USA
    Pain Med 8:S50-62. 2007
    ..The literature examining the epidemiology, quality of life burden, cost, and treatment of diabetic peripheral neuropathy pain (DPNP) in U.S. adults was reviewed...